Home › Funds › Trails Edge Capital Partners, LP › NERV

Trails Edge Capital Partners, LP position in NERV

MINERVA NEUROSCIENCES INC · Health Care

Trails Edge Capital Partners, LP reported holding 1,419,000 shares of NERV (MINERVA NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$7.9M, representing 1.25% of its reported portfolio and ranking #29 among its reported holdings. Trails Edge Capital Partners, LP has disclosed NERV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.42M sh
Reported value held$7.88M
Portfolio Weight1.25%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's NERV position evolved

Trails Edge Capital Partners, LP first disclosed a stake in NERV in Q1 2026 at 1,419,000 shares (US$8.5M). Across 2 filings, Trails Edge Capital Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,419,000 shares valued at US$7.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.42M $8.55M New
Q2 2026 1.42M $7.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NERV and 13F data

NERV (MINERVA NEUROSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in NERV — the largest reported positions include Vivo Capital, LLC (US$24.0M), Logos Global Management LP (US$18.3M), Ally Bridge Group (NY) LLC (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NERV

All NERV fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held NERV?

Trails Edge Capital Partners, LP has disclosed NERV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Trails Edge Capital Partners, LP's current position in NERV?

As of Q2 2026, Trails Edge Capital Partners, LP holds 1.42M shares of NERV (MINERVA NEUROSCIENCES INC), valued at $7.88M, representing 1.25% of its reported portfolio and ranking #29.

Has Trails Edge Capital Partners, LP been buying or selling NERV?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP held unchanged its position in NERV.

Which other funds hold NERV?

Other major institutional holders of NERV include Vivo Capital, LLC, Logos Global Management LP, Ally Bridge Group (NY) LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.